High Gross Margins (~70%)Serstech's ~70% gross margin reflects attractive product-level economics from its handheld Raman instruments. Durable hardware margins provide a structural buffer to absorb operating costs, support recurring software/library investment, and improve unit-level profitability as revenues scale over months.

Consistent Revenue GrowthRevenue growth of +10.6% demonstrates persistent demand for Serstech's chemical identification instruments and related software. Steady top-line expansion supports scale benefits, wider adoption in law enforcement/customs, and growth of recurring software/library revenue tied to installed devices.

Debt-free Balance SheetA reported absence of debt in TTM and 2024 lowers financial risk and preserves flexibility. The debt-free position gives management options to fund operations via cash, equity or modest financing, providing runway to execute strategy without recurring interest obligations.

Bears Say

Severely Deteriorated ProfitabilityNet margin around -49% and materially widened operating losses indicate the company is far from break-even. Such deep negative profitability is structural risk: it can erode capital, require sustained cost restructuring or significant revenue acceleration, and pressures long-term viability.

Material Negative Cash GenerationOperating cash flow of -18.9m and free cash flow of -23.5m show significant cash burn. Continued negative cash generation increases the likelihood of dilutive equity raises or external financing, constrains investment in growth, and elevates execution and funding risk over the coming months.

Erosion Of Equity And Negative ROEDeclining equity and assets alongside meaningfully negative returns on equity reflect erosion of the capital base. This weakens the company's balance-sheet resilience, limits strategic flexibility, and increases vulnerability to shocks absent a sustained turnaround or fresh capital.

284 FAQ

What was Serstech AB’s price range in the past 12 months?

Serstech AB lowest stock price was €0.03 and its highest was €0.10 in the past 12 months.

What is Serstech AB’s market cap?

Serstech AB’s market cap is €12.94M.

When is Serstech AB’s upcoming earnings report date?

Serstech AB’s upcoming earnings report date is Feb 27, 2026 which is in 22 days.

How were Serstech AB’s earnings last quarter?

Serstech AB released its earnings results on Nov 04, 2025. The company reported -€0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.002.

Is Serstech AB overvalued?

According to Wall Street analysts Serstech AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Serstech AB pay dividends?

Serstech AB does not currently pay dividends.

What is Serstech AB’s EPS estimate?

Serstech AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Serstech AB have?

Serstech AB has 254,319,050 shares outstanding.

What happened to Serstech AB’s price movement after its last earnings report?

Serstech AB reported an EPS of -€0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.452%.

Which hedge fund is a major shareholder of Serstech AB?

Currently, no hedge funds are holding shares in DE:284

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Serstech AB

Serstech AB provides chemical identification instruments worldwide. It offers the Serstech 100 Indicator, a handheld, small, and light Raman spectrometer for measuring chemicals, such as explosives, narcotics, toxic industrial chemicals, pharmaceuticals, and chemical warfare agents; and ChemDash, a central management software for Serstech devices. The company also provides Serstech Arx and Serstech Arx+ revolutionizing instruments for quick and precise identification of chemical substances; and Serstech's SERS kit that allows for quick identification of low concentrations and narcotics samples. It offers its solutions for explosive, CBRN and hazmat, narcotics, and pharma applications. Serstech AB was incorporated in 2006 and is headquartered in Lund, Sweden.